Sundar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 6.10 M
as on 11-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.00%
(FY 2017)
- Profit 11.79%
(FY 2017)
- Ebitda 13.99%
(FY 2017)
- Net Worth -7.36%
(FY 2017)
- Total Assets -4.66%
(FY 2017)
About Sundar Pharmaceuticals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramu Sundaravalli and Ramu Krishnan serve as directors at the Company.
- CIN/LLPIN
U24239TN2005PTC055911
- Company No.
055911
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- LocationChennai 600 018, Tamil Nadu
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sundar Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramu Sundaravalli  | Director | 08-Apr-2005 | Current |
| Ramu Krishnan | Director | 08-Apr-2005 | Current |
Financial Performance of Sundar Pharmaceuticals.
Sundar Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 25% increase. The company also saw a substantial improvement in profitability, with a 11.79% increase in profit. The company's net worth dipped by a decrease of 7.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundar Pharmaceuticals?
In 2017, Sundar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Babros Chemicals Private LimitedActive 50 years 7 monthsRamu Sundaravalli and Ramu Krishnan are mutual person
- Sundar Chemicals Private LimitedActive 37 years 10 months
Ramu Sundaravalli and Ramu Krishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sundar Pharmaceuticals?
Unlock and access historical data on people associated with Sundar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
